Shares of Jade Biosciences, Inc. (NASDAQ:JBIO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, six have assigned a buy […]